NO20092977L - Stabile, farmasoytiske legemiddelaerosoler - Google Patents
Stabile, farmasoytiske legemiddelaerosolerInfo
- Publication number
- NO20092977L NO20092977L NO20092977A NO20092977A NO20092977L NO 20092977 L NO20092977 L NO 20092977L NO 20092977 A NO20092977 A NO 20092977A NO 20092977 A NO20092977 A NO 20092977A NO 20092977 L NO20092977 L NO 20092977L
- Authority
- NO
- Norway
- Prior art keywords
- drug product
- container
- pharmaceutical drug
- fine particle
- stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2007/003637 WO2008097233A1 (en) | 2007-02-09 | 2007-02-09 | Stable pharmaceutical drug aerosols |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092977L true NO20092977L (no) | 2009-11-02 |
Family
ID=38610578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092977A NO20092977L (no) | 2007-02-09 | 2009-09-08 | Stabile, farmasoytiske legemiddelaerosoler |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP2117504A1 (ja) |
JP (1) | JP2010518076A (ja) |
KR (1) | KR20100004993A (ja) |
CN (1) | CN101652123A (ja) |
AU (1) | AU2007346134A1 (ja) |
BR (1) | BRPI0721256A2 (ja) |
CA (1) | CA2677347A1 (ja) |
MX (1) | MX2009008572A (ja) |
NO (1) | NO20092977L (ja) |
WO (1) | WO2008097233A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011136754A1 (en) * | 2010-04-26 | 2011-11-03 | Mahmut Bilgic | A medicament developed for the treatment of respiratory diseases |
KR102462058B1 (ko) * | 2014-10-08 | 2022-11-01 | 잠본쏘시에떼퍼아찌오니 | 제제의 안정성을 증가시키기 위해 분무 건조에 의해 수득된 1종 이상의 건조 분말을 포함하는 조성물 |
GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
EP3701940A1 (en) | 2015-12-04 | 2020-09-02 | Mexichem Fluor S.A. de C.V. | Pharmaceutical composition |
CN107961217B (zh) * | 2016-10-18 | 2021-06-29 | 天津金耀集团有限公司 | 一种糠酸莫米松气雾剂组合物 |
CN109464429B (zh) * | 2018-12-13 | 2021-04-27 | 上海方予健康医药科技有限公司 | 一种吸入压力定量气雾剂药物组合物及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5653961A (en) * | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
JP3264496B2 (ja) * | 1996-08-29 | 2002-03-11 | シェーリング コーポレイション | クロロフルオロカーボンを含まないモメタゾンフロエートエーロゾルの処方物 |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
EP1241113A1 (en) * | 2001-03-12 | 2002-09-18 | CHIESI FARMACEUTICI S.p.A. | Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
GB0207906D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and mometasone aerosol formulations |
EP1878664B1 (en) | 2002-08-27 | 2011-03-30 | Schering Corporation | Process for producing metered dose inhaler formulations |
US20050136009A1 (en) * | 2003-10-20 | 2005-06-23 | Schering Corporation | Pharmaceutical compositions |
-
2007
- 2007-02-09 EP EP07750471A patent/EP2117504A1/en not_active Ceased
- 2007-02-09 CN CN200780052493A patent/CN101652123A/zh active Pending
- 2007-02-09 KR KR1020097018157A patent/KR20100004993A/ko not_active Application Discontinuation
- 2007-02-09 MX MX2009008572A patent/MX2009008572A/es not_active Application Discontinuation
- 2007-02-09 WO PCT/US2007/003637 patent/WO2008097233A1/en active Application Filing
- 2007-02-09 BR BRPI0721256-9A patent/BRPI0721256A2/pt not_active IP Right Cessation
- 2007-02-09 CA CA002677347A patent/CA2677347A1/en not_active Abandoned
- 2007-02-09 EP EP12151231A patent/EP2444080A3/en not_active Withdrawn
- 2007-02-09 JP JP2009549054A patent/JP2010518076A/ja active Pending
- 2007-02-09 AU AU2007346134A patent/AU2007346134A1/en not_active Abandoned
-
2009
- 2009-09-08 NO NO20092977A patent/NO20092977L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2444080A3 (en) | 2012-05-02 |
BRPI0721256A2 (pt) | 2013-03-12 |
EP2444080A2 (en) | 2012-04-25 |
CA2677347A1 (en) | 2008-08-14 |
CN101652123A (zh) | 2010-02-17 |
MX2009008572A (es) | 2009-10-19 |
WO2008097233A1 (en) | 2008-08-14 |
JP2010518076A (ja) | 2010-05-27 |
EP2117504A1 (en) | 2009-11-18 |
AU2007346134A1 (en) | 2008-08-14 |
KR20100004993A (ko) | 2010-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20092977L (no) | Stabile, farmasoytiske legemiddelaerosoler | |
Herrera-Cruz et al. | Of yeast, mice and men: MAMs come in two flavors | |
Dramsi et al. | Listeriolysin O-mediated calcium influx potentiates entry of Listeria monocytogenes into the human Hep-2 epithelial cell line | |
Gutsche et al. | Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein | |
Yusupov et al. | Atomic-scale simulations of reactive oxygen plasma species interacting with bacterial cell walls | |
Wang et al. | Autophagy and cell reprogramming | |
Susanto et al. | Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis | |
Shen et al. | Modelling cadmium‐induced cardiotoxicity using human pluripotent stem cell‐derived cardiomyocytes | |
RU2020105325A (ru) | Культуральная среда стволовых клеток | |
Lee et al. | Embryonic stem cells: a novel paradigm to study proteostasis? | |
Li et al. | Honokiol inhibits LPS‐induced maturation and inflammatory response of human monocyte‐derived dendritic cells | |
BR112013008364A2 (pt) | filtros de fumaça para dispositivos de fumar com massas porosas tendo uma carga de partícula de carbono e uma queda de pressão encapsulada | |
NO20075166L (no) | Dendrittiske celleblandinger og fremgangsmater | |
Mellouk et al. | Cytosolic access of intracellular bacterial pathogens: the Shigella paradigm | |
WO2006101633A3 (en) | Apparatus and method for identifying asynchronous data in redundant data stores and for re-synchronizing same | |
BR112012012463A2 (pt) | método e aparelho para apresentação de segmentos de mídia | |
Kim et al. | Regulatory effect of cinnamaldehyde on monocyte/macrophage‐mediated inflammatory responses | |
Kharlamova et al. | Vapor treatment of electrospray droplets: evidence for the folding of initially denatured proteins on the sub-millisecond time-scale | |
Mollo et al. | Targeting mitochondrial network architecture in Down syndrome and aging | |
BR112013028257A2 (pt) | "composição de fármaco biológico, métodos de manipulação de uma composição de fármaco biológica com células vivas e de fornecer composições de células vivas em um ponto de instalação de tratamento, bem como uso de células vivas formuladas em tampão não nutritivo" | |
BR112012006319B8 (pt) | sistema de dispensação de medicamentos automatizado, dispositivo de mão, sistema de administração de cabeceira e método para verificação da dispensação de um item | |
Wahlin et al. | Modeling retinal dystrophies using patient-derived induced pluripotent stem cells | |
Ghodasara et al. | Clinical translation of extracellular vesicles | |
Wojciechowski et al. | Choice of Capping Group in Tripeptide Hydrogels Influences Viability in the Three‐Dimensional Cell Culture of Tumor Spheroids | |
Gianì et al. | The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: MERCK SHARP AND DOHME CORP, US Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |